After a bit of dithering, I've added s modest position in CCG to my portfolio.
There's a lot to like about CCG - it's operating in businesses characterised by industry tailwinds, no debt, net cash, solid top line and EBIDTA growth forecast, big-name business partners, management with skin in the game and undemanding multiples for the industry. Potential as a takeover target is noted but not part of my analysis.
Things I didn't like - employee compensation is a very high percentage of revenue for this type of business (but should come down as the company scales up) and I see no prospect of a dividend in the near term.
Thanks to all those who've posted.
- Forums
- ASX - By Stock
- CCG
- Ann: Vodafone partnership delivers CCG services to Pacific region
Ann: Vodafone partnership delivers CCG services to Pacific region, page-23
Featured News
Add CCG (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.9¢ |
Change
0.001(1.28%) |
Mkt cap ! $30.63M |
Open | High | Low | Value | Volume |
7.9¢ | 7.9¢ | 7.9¢ | $25.57K | 323.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 75000 | 7.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.0¢ | 99000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 75000 | 0.077 |
1 | 274581 | 0.076 |
1 | 50000 | 0.071 |
2 | 24297 | 0.070 |
1 | 500000 | 0.069 |
Price($) | Vol. | No. |
---|---|---|
0.080 | 99000 | 2 |
0.082 | 133334 | 1 |
0.089 | 330000 | 1 |
0.090 | 100793 | 2 |
0.100 | 217312 | 1 |
Last trade - 12.27pm 10/10/2024 (20 minute delay) ? |
Featured News
CCG (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online